Zacks Investment Research lowered shares of HCA Holdings, Inc. (NYSE:HCA) from a hold rating to a sell rating in a report issued on Tuesday morning.

According to Zacks, “HCA Healthcare’s shares have lost value in six months' time. The company continues to suffer from weak commercial business that has faced declining volumes of admissions over the last four to five quarters. Its high bad debts and disappointing international business are the other headwinds. The company has also trimmed its 2017 guidance which bothers us. The stock has seen the Zacks Consensus Estimate for current-year earnings being revised 2% downward over the last 60 days. Its top-line has been growing over the past several quarters on strong volumes and improved payor and service mix. A number of acquisitions made over the past many years have helped the company gain a strong foothold in the industry. “

A number of other equities analysts also recently weighed in on the stock. ValuEngine downgraded shares of HCA Holdings from a buy rating to a hold rating in a report on Thursday, September 7th. Argus started coverage on shares of HCA Holdings in a report on Wednesday, June 28th. They issued a buy rating and a $100.00 price target on the stock. KeyCorp reissued a buy rating and issued a $95.00 price target on shares of HCA Holdings in a report on Thursday, September 7th. BidaskClub downgraded shares of HCA Holdings from a hold rating to a sell rating in a report on Monday, July 24th. Finally, Bank of America Corporation downgraded shares of HCA Holdings from a buy rating to a neutral rating and cut their price target for the stock from $102.00 to $92.00 in a report on Wednesday, July 26th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the stock. The stock currently has an average rating of Buy and an average target price of $92.79.

Shares of HCA Holdings (NYSE HCA) traded up 1.35% during mid-day trading on Tuesday, reaching $77.86. 1,599,856 shares of the company’s stock were exchanged. HCA Holdings has a 52-week low of $67.00 and a 52-week high of $91.03. The company’s 50-day moving average price is $77.65 and its 200 day moving average price is $82.18. The company has a market cap of $28.13 billion, a PE ratio of 10.44 and a beta of 0.62.

HCA Holdings (NYSE:HCA) last issued its quarterly earnings results on Tuesday, July 25th. The company reported $1.75 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.80 by ($0.05). The company had revenue of $10.73 billion during the quarter, compared to analysts’ expectations of $10.76 billion. HCA Holdings had a negative return on equity of 48.08% and a net margin of 6.64%. HCA Holdings’s quarterly revenue was up 4.0% compared to the same quarter last year. During the same period last year, the firm posted $1.66 earnings per share. On average, equities research analysts predict that HCA Holdings will post $7.11 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “HCA Holdings, Inc. (HCA) Downgraded to Sell at Zacks Investment Research” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another domain, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this article can be accessed at https://www.thecerbatgem.com/2017/10/18/hca-holdings-inc-hca-downgraded-to-sell-at-zacks-investment-research.html.

In related news, insider Michael S. Cuffe sold 2,150 shares of the company’s stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $79.87, for a total value of $171,720.50. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. 2.90% of the stock is currently owned by corporate insiders.

Hedge funds have recently bought and sold shares of the stock. Northwestern Mutual Wealth Management Co. increased its position in shares of HCA Holdings by 14.0% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,163 shares of the company’s stock worth $101,000 after purchasing an additional 143 shares during the last quarter. Bronfman E.L. Rothschild L.P. increased its position in shares of HCA Holdings by 35.1% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 1,232 shares of the company’s stock worth $107,000 after purchasing an additional 320 shares during the last quarter. Atlantic Trust LLC bought a new position in shares of HCA Holdings in the second quarter worth approximately $118,000. Lee Financial Co bought a new position in shares of HCA Holdings in the second quarter worth approximately $125,000. Finally, Acrospire Investment Management LLC increased its position in shares of HCA Holdings by 14.3% in the second quarter. Acrospire Investment Management LLC now owns 1,600 shares of the company’s stock worth $140,000 after purchasing an additional 200 shares during the last quarter. Institutional investors own 73.76% of the company’s stock.

HCA Holdings Company Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Analyst Recommendations for HCA Holdings (NYSE:HCA)

Receive News & Stock Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related stocks with our FREE daily email newsletter.